Chemotherapy of Advanced Non-Hodgkin Lymphomas: A Report of 35 Cases

Abstract

Italian

Thirty-five patients with stage III and IV non-Hodgkin lymphomas, classified according to Lennert have been treated by combination chemotherapy (CVP). Total remission (complete plus partial) was obtained in 68.5% of the cases and complete remission in 28.5%; 73% of the favorable types and 55% of the unfavorable histologic types achieved tumor response: the difference was not statistically significant, perhaps because of the limited number of cases. Median survival was 14 months for the unfavorable histologic types and 28 months for the favorable types; longer survivals were obtained in patients who achieved complete remission. CHOP regimen after CVP in patients refractory to this type of treatment was not satisfactory in our patients.

Get full access to this article

View all access options for this article.

References

Anderson

Bender

R.A.

Fisher

R.I.

De Vita

V.T.

Chabner

B.A.

Berard

C.W.

Norton

Young

R.C.

: Combination chemotherapy in non-Hodgkin's lymphoma: Results of long-term follow-up. Cancer Treat. Rep., 61: 1057–1066, 1977.

Bagley

C.M.

De Vita

V.T.

Berard

C.W.

Canellos

G.P.

: Advanced lymphosarcoma: Intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Ann. Intern. Med., 76: 227–234, 1972.

Bettini

Chelazzi

Incarbone

: Linfomi maligni non-Hodgkin: Rilievi su una casistica di 174 malati. Recent Prog. Med., 69: 138–157, 1980.

Bonadonna

Castellani

Narduzzi

Spinelli

Rilke

: Pathological staging in adults previously untreated non-Hodgkin's lymphomas. In: Recent Results in Cancer Research, 65, 41. Mathè

Seligmann

Tubiana

Eds., Springer-Verlag, Berlin, Heidelberg, 1978.

Comella

Abate

Comella

Bruni

G.S.

Zarrilli

Pergola

: Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin lmphomas with unfavorable histology: Preliminary results. Tumori, 66: 749–756, 1980.

Fisher

R.I.

Hubbard

S.M.

De Vita

V.T.

Berard

C.W.

Wesley

Cossman

Young

R.C.

: Factors predicting long-term survival in diffuse mixed histiocytic or undifferentiated lymphoma. Blood, 58: 45–51, 1981.

Garvin

J.A.

Simon

Young

R.C.

De Vita

V.T.

Berard

C.W.

: The Rappaport classification of non-Hodgkin lymphomas: A closer look using other proposed classifications. Semin. Oncol., 7: 234–243, 1980.

Herait

Gerard-Marchant

Amiel

J.L.

Cailland

J.M.

Tursz

T.H.

Droz

J.P.

: Hematosarcomes non-Hodgkiniens. Nouv. Presse Med., 10: 2267–2271, 1981.

Jones

S.E.

Fuks

Bull

Kadin

M.E.

Dorfman

R.F.

Kaplan

H.S.

Rosenberg

S.A.

Kim

: Non-Hodgkin's lymphomas. IV. Clinico-pathologic correlation in 405 cases. Cancer, 31: 806–823, 1973.

10.

Kennedy

B.J.

Bloomfield

Kiang

: Combination (CVP) versus successive single agent chemotherapy (CVP) in lymphocytic lymphoma. Cancer, 41: 23–28, 1978.

11.

Lennert

Stein

Kaiserling

: New criteria for the classification of malignant lymphomas. In: Present Problems in Haematology. pp. 113, Excerpta Medica, Amsterdam, 1974.

12.

Lennert

: Malignant Lymphomas. Springer-Verlag, Berlin, Heidelberg, New York, 1978.

13.

Lewis

B.J.

De Vita

V.T.

: Combination therapy of the lymphomas. Semin. Haematol., 15: 413–457, 1978.

14.

Lister

T.A.

Cullen

M.H.

Beard

M.E.J.

: Comparison of combined and single agent chemotherapy in non-Hodgkin lymphomas of favourable histological type. Br. Med. J., 1: 533–537, 1978.

15.

Luce

J.K.

De Laney

F.C.

Gehan

E.A.

: Remission induction chemotherapy of disseminated malignant lymphomas with combination bleomycin, cyclophosphamide, vincristine and prednisone. In: Proceedings of the 64th Annual Meeting of the American Association for Cancer Research, 1973.

16.

Luce

J.K.

Gamble

J.F.

Wilson

H.E.

Monto

R.W.

Isaacs

B.L.

Palmer

R.J.

Cokman

C.A.

Hewlett

J.S.

Gehan

E.A.

Frej

III : Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphomas. Cancer, 28: 306–310, 1973.

17.

Lukes

R.J.

Collins

R.D.

: New approaches to the classification of lymphomas. Br. J. Cancer, 31, suppl. II: 1–28, 1975.

18.

Lukes

R.J.

Parker

J.W.

Taylor

C.R.

Tindle

B.H.

Cramer

A.D.

Lincoln

T.L.

: Immunological approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin. Hematol., 15: 322–351, 1978.

19.

McKelwey

E.M.

Gottlieb

J.A.

Wilson

H.E.

Haut

Talley

R.W.

Stephens

Lane

Gamble

J.F.

Jones

S.E.

Grozea

P.N.

Gutterman

Coltman

Jr. , Moon

T.E.

: Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphomas. Cancer, 38: 1484–1493, 1976.

20.

Meugè

Hoerni

De Mascarel

Durand

Richaud

Hoerni-Simon

Chauvergne

Lagarde

: Non-Hodgkin malignant lymphomas. Clinico-pathologic correlations with the Kiel classification. Retrospective analysis of a series of 274 cases. Eur. J. Cancer, 14: 587–592, 1978.

21.

Monfardini

Tancini

De Lena

Villa

Valagussa

Bonadonna

: Cyclophosphamide, vincristine and prednisone (CVP) versus adriamycin, bleomycin and prednisone (ABP) in stage IV non-Hodgkin's lymphomas. Med. Pediatr. Oncol., 3: 67–74, 1977.

22.

Monfardini

Villa

De Lena

: Principi generali per l'impiego della chemioterapia nei linfomi non-Hodgkin. In: Linfomi non-Hodgkin, pp. 173–179, Aggiornamenti sulla diagnosi e terapia. 1st. Naz. per lo Studio e la Cura dei Tumori. A.I.O.M. Ed., Milano, 1979.

23.

Nathwani

B.N.

Kim

Rappaport

Solomon

Fox

: Non-Hodgkin lymphomas: A clinicopathologic study comparing two classifications. Cancer, 41: 303–325, 1978.

24.

Portlock

C.S.

:, Rosenberg

S.A.

: Combination chemotherapy with cyclophosphamide, vincristine and prednisone in advanced non-Hodgkin's lymphomas. Cancer, 37: 1275–1282, 1976.

25.

Portlock

C.S.

Rosenberg

S.A.

Glatstein

Kaplan

: Treatment of advanced non-Hodgkin's lymphomas with favourable histologies: Preliminary results of a prospective trial. Blood, 47: 747–756, 1976.

26.

Rappaport

: Tumors of the hematopoietic system. Atlas of Tumor Pathology, p. 97. Section III, Fasc. 8. Armed Forces Institute of Pathology., Washington D.C., 1966.

27.

Rosenberg

S.A.

: Current concepts in cancer: Non-Hodgkin's lymphomas. Selection of treatment on the basis of histologic type. N. Engl. J. Med., 17: 924–928, 1979.

28.

Scheyn

P.S.

Chabner

B.A.

Canellos

G.P.

: Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphomas. Blood, 43: 181–189, 1974.

29.

Skarin

A.T.

Pinkus

G.S.

Myerowite

R.L.

Bishop

Y.M.

Moloney

W.C.

: Combination chemotherapy of advanced lymphocytic lymphomas. Importance of histologic classification in evaluating responses. Cancer, 34: 1023–1030, 1974.

30.

Stejn

R.S.

Cousar

J.B.

Flexner

J.M.

: Prognostic features in follicular center lymphomas. Proc. Am. Soc. Clin. Oncol., 20: 294–299, 1979.

31.

Young

R.C.

Johnson

R.E.

Canellos

G.P.

Chabner

B.A.

Brereton

H.D.

Berard

C.W.

Devita

V.T.

: Advanced lymphocytic lymphoma: Randomized comparison of chemotherapy and radiotherapy, alone or in combination. Cancer Treat. Rep., 61: 1153–1159, 1977.

32.

Young

R.C.

Anderson

Bender

R.A.

Norton

De Vita

V.T.

: Nodular mixed lymphoma (NML): Another potentially curable non-Hodgkin's lymphoma. Proc. Am. Soc. Clin. Oncol., 18: 356–364, 1977.

33.

Ziegler

: Clinical implication of new biological concepts of non-Hodgkin's lymphomas, pp. 230–232. In: Berard C.W., moderator. A Multidisciplinary Approach to non-Hodgkin's Lymphomas. Ann. Intern. Med., 94: 218–235, 1981.